Mental Health Weekly: Psychedelic therapies continue to be seen as big trend in MH treatment

I recently had the privilege of meeting with Valerie Canady of Mental Health Weekly to discuss the promising research suggesting that psychedelics are powerful tools in treating depression, PTSD, and other conditions. I feel confident that we’re just at the beginning of this major development in the world of psychiatry and mental health. MDMA will most likely be FDA approved for PTSD in 2022 or 2023. It’s looking like psilocybin for depression will follow suit. If you’d like to read the full article, check out the link below!